Phibro Animal Health (PAHC) vs uniQure N.V. (QURE)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Phibro Animal Health (PAHC) has outperformed uniQure N.V. (QURE) over the past year, gaining 3.0% versus a loss of 64.5%. Over five years, PAHC leads with a +75.7% price change compared with -24.9% for QURE. uniQure N.V. is the larger company by market cap ($1.57 billion vs $1.56 billion), about 1.0 times the size, while Phibro Animal Health is growing revenue faster (+17.1% vs -40.6%).
Phibro Animal Health pays a dividend yielding 1.25%, while uniQure N.V. does not currently pay one. Phibro Animal Health converts more of its revenue into profit, with a net margin of 6.6% versus -1236.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PAHC | QURE |
|---|---|---|
| Share price | $38.30 | $22.59 |
| Market cap | $1.56B | $1.57B |
| 1-day change | +2.41% | +0.22% |
| YTD return | +2.52% | -5.60% |
| 1-year return | +3.04% | -64.51% |
| 5-year return | +75.69% | -24.85% |
| P/E ratio (TTM) | 15.38 | — |
| Forward P/E | 9.97 | — |
| EPS (TTM) | $2.49 | $-4.03 |
| Dividend yield | 1.25% | 0.00% |
| Annual dividend | $0.48 | $0.00 |
| Revenue (latest FY) | $1.52B | $16.10M |
| Revenue growth (YoY) | +17.12% | -40.64% |
| Net income (latest FY) | $99.72M | $-198.97M |
| Gross margin | 33.76% | 89.53% |
| Operating margin | 12.81% | -1151.38% |
| Net margin | 6.57% | -1236.00% |
| 52-week high | $60.08 | $71.50 |
| 52-week low | $28.25 | $8.73 |
| Distance from 52-week high | -36.25% | -68.41% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +14.88% | +175.92% |
| Average volume | 236.19K | 1.97M |
| Shares outstanding | 21.11M | 69.37M |
| Employees | 2,605 | 221 |
| Sector | Healthcare | Health Care |
| Industry | Drug Manufacturers - Specialty & Generic | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PAHC has outperformed QURE by 67.5 percentage points over the past year.
- Phibro Animal Health offers a meaningfully higher dividend yield (1.25% vs 0.00%).
- Phibro Animal Health is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -1236.0 cents for uniQure N.V..
- Phibro Animal Health grew revenue faster in its latest fiscal year (+17.12% vs -40.64%).
- The two companies sit in different sectors: Phibro Animal Health in Healthcare and uniQure N.V. in Health Care.
About Phibro Animal Health
PAHC stock →Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products.
Healthcare · Drug Manufacturers - Specialty & Generic · 2,605 employees
About uniQure N.V.
QURE stock →uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 221 employees
PAHC vs QURE FAQ
Which is bigger, Phibro Animal Health or uniQure N.V.?
uniQure N.V. (QURE) is larger, with a market capitalization of $1.57B compared with $1.56B for Phibro Animal Health (PAHC).
Which stock has performed better over the past year, PAHC or QURE?
PAHC returned +3.04% over the past 12 months, compared with -64.51% for QURE (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Phibro Animal Health or uniQure N.V.?
Phibro Animal Health pays a dividend yielding 1.25%, while uniQure N.V. does not currently pay a regular dividend.
Are Phibro Animal Health and uniQure N.V. in the same industry?
No. Phibro Animal Health is in the Healthcare sector, while uniQure N.V. is in Health Care.